Home/Filings/4/0001214659-15-002044
4//SEC Filing

IGI LABORATORIES, INC 4

Accession 0001214659-15-002044

CIK 0000352998operating

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:12 PM ET

Size

16.5 KB

Accession

0001214659-15-002044

Insider Transaction Report

Form 4
Period: 2015-03-05
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
GALE JAMES C
Director10% Owner
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
Transactions
  • Sale

    Common Stock

    2015-03-05$9.95/sh303,680$3,021,6161,494,873 total
  • Sale

    Common Stock

    2015-03-05$9.95/sh1,696,320$16,878,3848,356,988 total
Footnotes (2)
  • [F1]These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW"), the controlling member of the General Partner, and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
  • [F2]These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, the controlling member of the General Partner, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.

Issuer

IGI LABORATORIES, INC

CIK 0000352998

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000352998

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:12 PM ET
Size
16.5 KB